全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

基于网络药理学探讨余甘子对痛风性关节炎的潜在作用机制
Study on the Potential Mechanism of Action of Phyllanthus emblica on Gouty Arthritis Based on Network Pharmacology

DOI: 10.12677/acm.2024.14102716, PP. 698-708

Keywords: 痛风性关节炎,余甘子,网络药理学
Gouty Arthritis
, Phyllanthus emblica, Network Pharmacology

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:本研究应用网络药理学探究余甘子治疗临床难治性疾病GA的主要活性成分和潜在机制,为云南特色药用植物余甘子用于GA的防治提供科学参考。方法:按照《网络药理学评选方法指南》采用网络数据库TCMSP和DisGeNET等获取余甘子的主要活性成分及其相关的蛋白质靶点和GA相关病理靶点。应用Venny2.1.0获取余甘子和GA靶点的集合,继而构建PPI网络,利用Cytoscape 3.9.1基于MCC算法得到核心靶点。进一步对靶点进行GO和KEGG富集分析。结果:筛选获得余甘子有效成分18个,余甘子和GA交集39个靶点,PPI网络中Degree值排序最重要的是TNF、VEGFA、MAPK14。GO分析表明余甘子治疗GA涉及小胶质细胞分化、凋亡细胞清除的正调节等生物过程。KEGG分析表明余甘子治疗GA的关键信号通路为Toll-like受体信号通路、NF-κB信号通路及IL-17信号通路。结论:通过本研究揭示了余甘子中槲皮素、木犀草素、山奈酚、鞣花酸等重要功效物质,通过调控关键炎症免疫信号通路及蛋白靶点,降低血液尿酸水平、减轻尿酸所致关节炎反应作为防治GA的潜在分子机制。
Objective: This study used network pharmacology to explore the main active ingredients and potential mechanisms of Phyllanthus emblica in the treatment of clinical refractory disease GA and to provide a scientific reference for the use of Phyllanthus emblica, a Yunnan specialty medicinal plant, in the prevention and treatment of GA. Method: According to the “Guidelines for Network Pharmacology Selection”, the main active ingredients of Phyllanthus emblica and their related protein and GA-related pathological targets were obtained using network databases such as TCMSP and DisGeNET. Venny2.1.0 was used to obtain the set of Phyllanthus emblica and GA targets, and then a PPI network was constructed. The core targets were obtained using Cytoscape 3.9.1 based on the MCC algorithm. GO and KEGG enrichment analyses were performed on the targets further. Results: A total of 18 active ingredients of Phyllanthus emblica and 39 targets in the intersection of Phyllanthus emblica and GA were screened and obtained. The most important degree values in the PPI network were TNF, VEGFA, and MAPK14. GO analysis showed that Phyllanthus emblica in the treatment of GA involved biological processes such as positive regulation of microglia differentiation and apoptotic cell clearance. KEGG analysis showed that the key signaling pathways of Phyllanthus emblica in treating GA were the Toll-like receptor signaling pathway, NF-κB signaling pathway, and IL-17 signaling pathway. Conclusion: This study revealed that quercetin, luteolin, kaempferol, ellagic acid, and other important functional substances in Phyllanthus emblica could reduce blood uric acid levels and alleviate uric acid-induced arthritis reactions as potential molecular mechanisms for the prevention and treatment of GA by regulating key inflammatory immune signaling pathways and protein targets.

References

[1]  Deng, P., Wang, S., Sun, X., Qi, Y., Ma, Z., Pan, X., et al. (2022) Global Trends in Research of Gouty Arthritis over Past Decade: A Bibliometric Analysis. Frontiers in Immunology, 13, Article 910400.
https://doi.org/10.3389/fimmu.2022.910400
[2]  方海琴, 姜萍, 王永俊, 等. 成人高尿酸血症与痛风食养指南(2024年版) [J]. 卫生研究, 2024, 53(3): 352-356.
[3]  Pu, M., Yao, C., Liu, L., Ren, L., Li, Y. and Xie, Y. (2021) Traditional Chinese Medicine for Gouty Arthritis: A Protocol for Meta-Analysis. Medicine, 100, e23699.
https://doi.org/10.1097/md.0000000000023699
[4]  Keyßer, G. (2020) Die Gichtarthritis: Pathogenese, Diagnostik und Behandlung. DMWDeutsche Medizinische Wochenschrift, 145, 991-1005.
https://doi.org/10.1055/a-1036-8348
[5]  刘晓晖, 吕乔, 吉雄, 等. 余甘子化学成分研究[J]. 中成药, 2023, 45(2): 458-462.
[6]  杨崇仁, 张颖君, 王海涛, 等. 余甘子应用源流考[J]. 亚太传统医药, 2021, 17(2): 197-200.
[7]  黄浩洲, 陈敬财, 张定堃, 等. 余甘子研究进展及质量标志物预测分析[J]. 中国中药杂志, 2021, 46(21): 5533-5544.
[8]  齐佳瑞, 孙静薇, 刘雅, 等. 基于网络药理学方法和细胞实验方法探究藏药余甘子抗三阴性乳腺癌的作用机制[J]. 中国高原医学与生物学杂志, 2023, 44(1): 27-36.
[9]  张玉蝶, 李欣, 何晓艳, 等. 余甘子醇提物对硅肺小鼠的保护作用及与Nrf2/ARE信号通路的相关性[J]. 中国实验方剂学杂志, 2023, 29(9): 129-136.
[10]  尹可欢, 罗晓敏, 丁翼, 等. 余甘子及其活性成分肝保护作用及机制的研究进展[J]. 中草药, 2022, 53(1): 295-307.
[11]  符晓晖. 抗痛风中药新药余甘子片的成药性研究[D]: [硕士学位论文]. 上海: 上海中医药大学, 2019.
[12]  世界中医药学会联合会. 网络药理学评价方法指南[J]. 世界中医药, 2021, 16(4): 527-532.
[13]  赵苗青, 李丰, 石彬彬, 等. 系统药理学(Ⅵ)——TCMSP数据库及其应用[J]. 中医药信息, 2020, 37(3): 22-29.
[14]  Adachi, S., Sasaki, K., Kondo, S., Komatsu, W., Yoshizawa, F., Isoda, H., et al. (2020) Antihyperuricemic Effect of Urolithin a in Cultured Hepatocytes and Model Mice. Molecules, 25, Article 5136.
https://doi.org/10.3390/molecules25215136
[15]  孙泽锐. 鞣花酸调节高尿酸血症的作用机理研究[D]: [硕士学位论文]. 昆明: 云南农业大学, 2022.
[16]  陈元堃, 曾奥, 罗振辉, 等. β-谷甾醇药理作用研究进展[J]. 广东药科大学学报, 2021, 37(1): 148-153.
[17]  丘志河, 谢卫勇, 黄刚, 等. 山奈酚通过调控miR-21/SOX9对骨关节炎软骨细胞增殖、凋亡的影响[J]. 中国药师, 2022, 25(12): 2073-2078.
[18]  谢凯莉, 李昭华, 董先智, 等. 槲皮素抑制黄嘌呤氧化酶活性的研究进展[J]. 时珍国医国药, 2019, 30(9): 2223-2225.
[19]  沈瑞明, 马丽辉, 郑颜萍. 木犀草素通过TLR/MyD88/NF-κB通路参与急性痛风性关节炎大鼠的抗炎作用[J]. 中南大学学报(医学版), 2020, 45(2): 115-122.
[20]  曾笑帅, 李慧辉, 吴惠明, 等. 加味柴苓汤结合穴位贴敷对急性痛风性关节炎患者血清IL-6、TNF-α表达的影响[J]. 中国地方病防治, 2023, 38(1): 70-73, 76.
[21]  周艺璇, 陈如一, 李芬芬, 等. 基于网络药理学探讨黄精防治痛风的机制[J]. 中国现代应用药学, 2023, 40(2): 154-162.
[22]  李倩, 靳子明, 张岩, 等. 基于环氧合酶2和血管内皮生长因子的骨关节炎病理机制及药物研究进展[J]. 风湿病与关节炎, 2023, 12(6): 60-64.
[23]  付凌萌, 王少康, 孙桂菊. 木犀草素活性功能研究进展[C]//中国营养学会, 亚太临床营养学会, 江苏省科学技术协会, 中国疾病预防控制中心营养与健康所, 农业农村部食物与营养发展研究所. 营养研究与临床实践——第十四届全国营养科学大会暨第十一届亚太临床营养大会、第二届全球华人营养科学家大会论文摘要汇编. 东南大学公共卫生学院环境医学工程教育部重点实验室/营养与食品卫生学系, 2019: 1.
[24]  郭云龙, 谢兴文, 李鼎鹏, 等. 中药调控痛风性关节炎相关信号通路研究进展[J]. 中国中医基础医学杂志, 2024, 30(5): 909-913.
[25]  刘静, 谢克琴, 曹跃朋, 等. TLRs/MyD88与痛风性关节炎的相关性研究[J]. 风湿病与关节炎, 2018, 7(4): 11-15.
[26]  周琦, 刘树民, 董婉茹. “TLR2/4-NF-κB”信号转导通路在痛风性关节炎发病中的作用机制[J]. 中国药师, 2016, 19(9): 1733-1736.
[27]  Silva, C.R., Saraiva, A.L., Rossato, M.F., Trevisan, G. and Oliveira, S.M. (2023) What Do We Know about Toll-Like Receptors Involvement in Gout Arthritis? Endocrine, Metabolic & Immune DisordersDrug Targets, 23, 446-457.
https://doi.org/10.2174/1871530322666220523145728
[28]  Bhadu, D., Choudhary, A., Goswami, R.P. and Kumar, U. (2024) AB0097 Role of TLR-4 and It’s Downregulatory Pathway in Acute Gouty Arthritis. Annals of the Rheumatic Diseases, 83, 1282.
https://doi.org/10.1136/annrheumdis-2024-eular.1984
[29]  Duan, T., Du, Y., Xing, C., Wang, H.Y. and Wang, R. (2022) Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity. Frontiers in Immunology, 13, Article 812774.
https://doi.org/10.3389/fimmu.2022.812774

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133